CLOs on the Move

Phathom Pharmaceuticals

www.phathompharma.com

 
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Karla Rowe
 Director, RandD Systems and Compliance Profile
Larry Miller
 General Counsel Profile

Similar Companies

Surgical Theater

Seamlessly integrating patient-specific surgical planning and navigation, professional education and rehearsal experiences with incredible VR-empowered patient engagement capabilities

Columbus Prescription Pharmacies

Columbus Prescription Pharmacies, Inc. is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Xanodyne Pharmaceuticals, Inc.

Xanodyne Pharmaceuticals, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Hepalife Technologies

Hepalife Technologies is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RSA Americas

RSA Americas is a Morristown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.